TUESDAY, Mar 27 (HealthDay News) — A new investigate finds that
women diagnosed with pre-cancerous cervical conditions after they get the
human papillomavirus (HPV) vaccine can still advantage from a shot because
it cuts their risk of destiny HPV-related cervical disease.
“This investigate helps to explain a effects of a HPV vaccine and further
define a use,” remarkable one expert, Dr. Elizabeth Poynor, a gynecologic
oncologist and pelvic surgeon during Lenox Hill Hospital in New York City.
Poynor, who was not concerned in a new research, pronounced it “is a first
to residence a outcome of a HPV vaccine in women who have undergone
treatment for HPV-related disease.”
The investigate was published online Mar 27 in a BMJ.
HPV stays a many common intimately transmitted infection in the
United States and can means health problems trimming from genital warts tocervical cancer, according to a U.S....
0 comments
Post a Comment